Cheri Ackerman

Cheri Ackerman is co-founder and CEO of Concerto Biosciences. Previously, she was an NIH Kirschstein Postdoctoral Fellow at the Broad Institute of MIT and Harvard. Ackerman earned her Ph.D. in chemistry as a Hertz Fellow at UC Berkeley where she also served on the Chemistry Graduate Life Committee. She holds a B.S. in biochemistry and Spanish from Calvin University.